Pacira Historical Financial Ratios

PCRX Stock

USD 17.38 0.35 2.06%

Pacira BioSciences, is promptly reporting on over 108 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Book Value Per Share of 19.77, Free Cash Flow Yield of 0.0939, Invested Capital of 0.0 or Operating Cash Flow Per Share of 3.51 will help investors to properly organize and evaluate Pacira BioSciences, financial condition quickly.

Quick Ratio Current Ratio

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pacira BioSciences,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more information on how to buy Pacira Stock please use our How to Invest in Pacira BioSciences, guide.

About Pacira Financial Ratios Analysis

Pacira BioSciences,Financial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Pacira BioSciences, investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Pacira financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Pacira BioSciences, history.

Pacira BioSciences, Financial Ratios Chart

At this time, Pacira BioSciences,'s Interest Coverage is fairly stable compared to the past year. Payout Ratio is likely to rise to 0.06 in 2024, whereas Price To Sales Ratio is likely to drop 2.19 in 2024.

Price To Sales Ratio Dividend Yield Ptb Ratio Days Sales Outstanding Debt Ratio

Add Fundamental

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Pacira BioSciences, stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Pacira BioSciences, sales, a figure that is much harder to manipulate than other Pacira BioSciences, multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Dividend Yield

Dividend Yield is Pacira BioSciences, dividend as a percentage of Pacira BioSciences, stock price. Pacira BioSciences, dividend yield is a measure of Pacira BioSciences, stock productivity, which can be interpreted as interest rate earned on an Pacira BioSciences, investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.

Ptb Ratio

Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.

Most ratios from Pacira BioSciences,'s fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Pacira BioSciences, current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pacira BioSciences,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For more information on how to buy Pacira Stock please use our How to Invest in Pacira BioSciences, guide.At this time, Pacira BioSciences,'s Interest Coverage is fairly stable compared to the past year. Payout Ratio is likely to rise to 0.06 in 2024, whereas Price To Sales Ratio is likely to drop 2.19 in 2024.

	2021	2023	2024 (projected)
Dividend Yield	0.001004	0.001154	0.001442
Price To Sales Ratio	4.92	2.31	2.19

Dividend Yield Price To Sales Ratio

Pacira BioSciences, fundamentals Correlations

	Price To Sales Ratio	Dividend Yield	Ptb Ratio	Days Sales Outstanding	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Capex To Depreciation	Pb Ratio	Ev To Sales	Free Cash Flow Per Share	Roic	Inventory Turnover	Net Income Per Share	Days Of Inventory On Hand	Payables Turnover	Capex To Revenue	Cash Per Share	Pocfratio	Interest Coverage	Payout Ratio	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding	Income Quality	Roe
Price To Sales Ratio		0.41	0.88	-0.07	-0.76	0.31	0.24	0.65	0.88	0.99	0.25	0.24	0.01	0.29	-0.06	0.48	0.24	-0.53	0.02	-0.36	-0.46	0.0	0.18	-0.35	0.09	0.08
Dividend Yield	0.41		0.34	-0.3	-0.8	-0.2	-0.27	0.41	0.34	0.34	-0.25	-0.27	0.34	-0.24	-0.35	-0.28	0.41	-0.22	0.17	-0.49	-0.96	0.06	-0.09	0.29	-0.22	-0.33
Ptb Ratio	0.88	0.34		0.15	-0.57	0.19	0.13	0.42	1.0	0.9	0.14	0.13	-0.09	0.16	-0.07	0.54	0.0	-0.41	-0.13	-0.16	-0.36	-0.06	0.11	-0.27	0.06	-0.05
Days Sales Outstanding	-0.07	-0.3	0.15		0.3	-0.52	-0.5	-0.17	0.15	-0.06	-0.51	-0.53	0.3	-0.52	-0.2	0.12	0.21	0.47	-0.54	-0.06	0.28	-0.5	0.07	0.42	0.18	-0.58
Book Value Per Share	-0.76	-0.8	-0.57	0.3		-0.16	-0.08	-0.66	-0.57	-0.71	-0.1	-0.08	-0.28	-0.13	0.24	-0.12	-0.43	0.51	-0.12	0.56	0.87	-0.07	0.01	0.1	0.12	0.04
Free Cash Flow Yield	0.31	-0.2	0.19	-0.52	-0.16		1.0	-0.01	0.19	0.37	1.0	0.99	-0.47	1.0	0.45	0.54	-0.53	-0.77	0.19	0.36	0.21	0.29	-0.01	-0.96	-0.06	0.95
Operating Cash Flow Per Share	0.24	-0.27	0.13	-0.5	-0.08	1.0		-0.07	0.13	0.3	1.0	1.0	-0.5	1.0	0.48	0.53	-0.58	-0.73	0.2	0.43	0.28	0.31	0.0	-0.96	-0.05	0.97
Capex To Depreciation	0.65	0.41	0.42	-0.17	-0.66	-0.01	-0.07		0.42	0.61	-0.07	-0.05	0.01	-0.01	0.14	0.19	0.52	-0.14	0.24	-0.53	-0.52	0.31	0.04	-0.03	0.17	-0.1
Pb Ratio	0.88	0.34	1.0	0.15	-0.57	0.19	0.13	0.42		0.9	0.14	0.13	-0.09	0.16	-0.07	0.54	0.0	-0.41	-0.13	-0.16	-0.36	-0.06	0.11	-0.27	0.06	-0.05
Ev To Sales	0.99	0.34	0.9	-0.06	-0.71	0.37	0.3	0.61	0.9		0.32	0.31	-0.08	0.35	0.0	0.55	0.15	-0.55	0.01	-0.29	-0.4	0.01	0.15	-0.42	0.08	0.14
Free Cash Flow Per Share	0.25	-0.25	0.14	-0.51	-0.1	1.0	1.0	-0.07	0.14	0.32		0.99	-0.49	1.0	0.46	0.53	-0.57	-0.74	0.19	0.41	0.26	0.29	0.0	-0.96	-0.06	0.97
Roic	0.24	-0.27	0.13	-0.53	-0.08	0.99	1.0	-0.05	0.13	0.31	0.99		-0.54	0.99	0.52	0.53	-0.61	-0.7	0.25	0.45	0.27	0.36	-0.01	-0.96	-0.07	0.98
Inventory Turnover	0.01	0.34	-0.09	0.3	-0.28	-0.47	-0.5	0.01	-0.09	-0.08	-0.49	-0.54		-0.48	-0.76	-0.45	0.69	0.14	-0.33	-0.42	-0.35	-0.44	0.05	0.56	0.09	-0.57
Net Income Per Share	0.29	-0.24	0.16	-0.52	-0.13	1.0	1.0	-0.01	0.16	0.35	1.0	0.99	-0.48		0.46	0.54	-0.53	-0.75	0.2	0.37	0.24	0.3	0.0	-0.96	-0.06	0.96
Days Of Inventory On Hand	-0.06	-0.35	-0.07	-0.2	0.24	0.45	0.48	0.14	-0.07	0.0	0.46	0.52	-0.76	0.46		0.21	-0.53	-0.03	0.44	0.52	0.3	0.59	-0.15	-0.44	-0.07	0.58
Payables Turnover	0.48	-0.28	0.54	0.12	-0.12	0.54	0.53	0.19	0.54	0.55	0.53	0.53	-0.45	0.54	0.21		-0.29	-0.54	-0.21	0.02	0.25	-0.03	0.28	-0.72	0.25	0.42
Capex To Revenue	0.24	0.41	0.0	0.21	-0.43	-0.53	-0.58	0.52	0.0	0.15	-0.57	-0.61	0.69	-0.53	-0.53	-0.29		0.12	-0.31	-0.88	-0.45	-0.42	0.04	0.53	0.18	-0.65
Cash Per Share	-0.53	-0.22	-0.41	0.47	0.51	-0.77	-0.73	-0.14	-0.41	-0.55	-0.74	-0.7	0.14	-0.75	-0.03	-0.54	0.12		0.06	0.12	0.18	-0.01	0.02	0.76	-0.06	-0.59
Pocfratio	0.02	0.17	-0.13	-0.54	-0.12	0.19	0.2	0.24	-0.13	0.01	0.19	0.25	-0.33	0.2	0.44	-0.21	-0.31	0.06		0.36	-0.21	0.9	-0.08	-0.11	-0.01	0.35
Interest Coverage	-0.36	-0.49	-0.16	-0.06	0.56	0.36	0.43	-0.53	-0.16	-0.29	0.41	0.45	-0.42	0.37	0.52	0.02	-0.88	0.12	0.36		0.53	0.45	0.01	-0.32	-0.08	0.52
Payout Ratio	-0.46	-0.96	-0.36	0.28	0.87	0.21	0.28	-0.52	-0.36	-0.4	0.26	0.27	-0.35	0.24	0.3	0.25	-0.45	0.18	-0.21	0.53		-0.11	0.08	-0.3	0.24	0.33
Capex To Operating Cash Flow	0.0	0.06	-0.06	-0.5	-0.07	0.29	0.31	0.31	-0.06	0.01	0.29	0.36	-0.44	0.3	0.59	-0.03	-0.42	-0.01	0.9	0.45	-0.11		-0.22	-0.24	0.07	0.44
Pfcf Ratio	0.18	-0.09	0.11	0.07	0.01	-0.01	0.0	0.04	0.11	0.15	0.0	-0.01	0.05	0.0	-0.15	0.28	0.04	0.02	-0.08	0.01	0.08	-0.22		-0.1	-0.07	0.0
Days Payables Outstanding	-0.35	0.29	-0.27	0.42	0.1	-0.96	-0.96	-0.03	-0.27	-0.42	-0.96	-0.96	0.56	-0.96	-0.44	-0.72	0.53	0.76	-0.11	-0.32	-0.3	-0.24	-0.1		-0.06	-0.91
Income Quality	0.09	-0.22	0.06	0.18	0.12	-0.06	-0.05	0.17	0.06	0.08	-0.06	-0.07	0.09	-0.06	-0.07	0.25	0.18	-0.06	-0.01	-0.08	0.24	0.07	-0.07	-0.06		-0.09
Roe	0.08	-0.33	-0.05	-0.58	0.04	0.95	0.97	-0.1	-0.05	0.14	0.97	0.98	-0.57	0.96	0.58	0.42	-0.65	-0.59	0.35	0.52	0.33	0.44	0.0	-0.91	-0.09

Click cells to compare fundamentals

Pacira BioSciences, Account Relationship Matchups

Pacira BioSciences, fundamentals Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Price To Sales Ratio	4.47	6.07	4.92	2.64	2.31	2.19
Ptb Ratio	5.3	4.12	3.65	2.27	1.79	1.7
Days Sales Outstanding	41.21	46.01	64.92	53.86	57.08	37.42
Book Value Per Share	8.55	14.52	16.5	17.03	18.83	19.77
Free Cash Flow Yield	0.0321	0.0154	0.03	0.0655	0.0894	0.0939
Operating Cash Flow Per Share	1.7	1.81	2.84	3.19	3.35	3.51
Stock Based Compensation To Revenue	0.0941	0.0799	0.0949	0.078	0.0721	0.071
Capex To Depreciation	0.52	1.9	1.61	0.33	0.2	0.19
Pb Ratio	5.3	4.12	3.65	2.27	1.79	1.7
Free Cash Flow Per Share	1.45	0.92	1.8	2.53	3.02	3.17
Roic	0.0587	0.31	0.0548	0.0487	0.0428	0.045
Inventory Turnover	1.83	1.81	1.42	2.07	1.77	1.68
Net Income Per Share	(0.0115)	(0.27)	3.41	0.95	0.35	0.91
Days Of Inventory On Hand	199.4	201.12	256.47	175.94	206.25	118.98
Payables Turnover	8.34	11.25	13.3	13.09	11.76	7.23
Capex To Revenue	0.0241	0.0898	0.0847	0.0451	0.0225	0.0213
Cash Per Share	7.03	12.23	14.83	6.34	6.03	8.93
Pocfratio	26.67	33.15	21.18	12.1	10.08	9.58
Interest Coverage	1.61	1.81	4.13	1.5	4.32	4.53
Capex To Operating Cash Flow	0.14	0.49	0.36	0.21	0.098	0.0931
Pfcf Ratio	31.15	65.09	33.35	15.26	11.18	11.74
Days Payables Outstanding	43.78	32.45	27.44	27.87	31.03	29.48
Income Quality	(6.4)	0.53	2.99	9.13	3.69	3.87
Roe	(0.031)	0.23	0.0575	0.0205	0.0482	0.0506
Ev To Operating Cash Flow	30.55	38.87	25.51	16.64	12.88	23.5
Pe Ratio	(170.71)	17.55	63.44	110.48	37.17	39.03
Return On Tangible Assets	(0.0176)	0.13	0.0321	0.0163	0.0452	0.0475
Ev To Free Cash Flow	35.69	76.33	40.16	20.98	14.28	15.0
Earnings Yield	(0.005858)	0.057	0.0158	0.009052	0.0269	0.0282
Intangibles To Total Assets	0.25	0.15	0.37	0.42	0.41	0.43
Net Debt To E B I T D A	4.95	6.18	4.59	4.55	2.66	2.79
Current Ratio	3.79	2.57	1.66	3.37	5.24	5.5
Tangible Book Value Per Share	3.64	9.93	(0.88)	1.56	4.84	5.08
Receivables Turnover	8.86	7.93	5.62	6.78	6.39	9.03
Graham Number	7.14	33.38	18.77	11.57	19.61	37.65

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Pacira Stock Analysis

When running Pacira BioSciences,'s price analysis, check to measure Pacira BioSciences,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pacira BioSciences, is operating at the current time. Most of Pacira BioSciences,'s value examination focuses on studying past and present price action to predict the probability of Pacira BioSciences,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pacira BioSciences,'s price. Additionally, you may evaluate how the addition of Pacira BioSciences, to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Graham Number	Shareholders Equity Per Share
Debt To Equity	Capex Per Share
Graham Net Net	Average Receivables
Revenue Per Share	Interest Debt Per Share
Debt To Assets	Enterprise Value Over E B I T D A
Short Term Coverage Ratios	Price Earnings Ratio
Operating Cycle	Price Book Value Ratio
Price Earnings To Growth Ratio	Days Of Payables Outstanding
Dividend Payout Ratio	Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio	Pretax Profit Margin
Ebt Per Ebit	Operating Profit Margin
Effective Tax Rate	Company Equity Multiplier
Long Term Debt To Capitalization	Total Debt To Capitalization
Return On Capital Employed	Debt Equity Ratio
Ebit Per Revenue	Quick Ratio
Dividend Paid And Capex Coverage Ratio	Net Income Per E B T
Cash Ratio	Cash Conversion Cycle
Operating Cash Flow Sales Ratio	Days Of Inventory Outstanding
Days Of Sales Outstanding	Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios	Price To Book Ratio
Fixed Asset Turnover	Capital Expenditure Coverage Ratio
Price Cash Flow Ratio	Enterprise Value Multiple
Debt Ratio	Cash Flow To Debt Ratio
Price Sales Ratio	Return On Assets
Asset Turnover	Net Profit Margin
Gross Profit Margin	Price Fair Value
Return On Equity

Pacira Historical Financial Ratios

About Pacira Financial Ratios Analysis

Pacira BioSciences, Financial Ratios Chart

Price To Sales Ratio

Dividend Yield

Ptb Ratio

Pacira BioSciences, fundamentals Correlations

Pacira BioSciences, Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Pacira BioSciences, fundamentals Accounts

Also Currently Popular

Additional Tools for Pacira Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Pb Ratio	+ 1.0	Ptb Ratio
Operating Cash Flow Per Share	+ 1.0	Free Cash Flow Yield
Free Cash Flow Per Share	+ 1.0	Free Cash Flow Yield
Net Income Per Share	+ 1.0	Free Cash Flow Yield
Free Cash Flow Per Share	+ 1.0	Operating Cash Flow Per Share
Roic	+ 1.0	Operating Cash Flow Per Share

Days Payables Outstanding	- 0.96	Net Income Per Share
Days Payables Outstanding	- 0.96	Roic
Days Payables Outstanding	- 0.96	Free Cash Flow Per Share
Days Payables Outstanding	- 0.96	Operating Cash Flow Per Share
Days Payables Outstanding	- 0.96	Free Cash Flow Yield
Payout Ratio	- 0.96	Dividend Yield